Retatrutide creates a window of opportunity for fat loss, not a permanent solution
Unlike other medications like tirzepatide, Retatrutide targets three receptors: GLP-1, GIP, and glucagon (GCG), enhancing its effectiveness
Assignment to treatment group was determined by a computer-generated random sequence using a validated interactive web-response system
This personalized approach often yields faster, more sustainable results than starting therapy while lactating
Consequently, these studies help researchers observe significant changes in fat oxidation and insulin sensitivity within controlled laboratory models
International Journal of Obesity (2005), 45 (3), 639649